These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 20386361

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand.
    Vanprapar N, Cressey TR, Chokephaibulkit K, Muresan P, Plipat N, Sirisanthana V, Prasitsuebsai W, Hongsiriwan S, Chotpitayasunondh T, Eksaengsri A, Toye M, Smith ME, McIntosh K, Capparelli E, Yogev R, IMPAACT P1056 Team.
    Pediatr Infect Dis J; 2010 Oct; 29(10):940-4. PubMed ID: 20453709
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
    Fillekes Q, Mulenga V, Kabamba D, Kankasa C, Thomason MJ, Cook A, Ferrier A, Chintu C, Walker AS, Gibb DM, Burger DM.
    AIDS; 2012 Sep 10; 26(14):1795-800. PubMed ID: 22739394
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children.
    Corbett AH, Hosseinipour MC, Nyirenda J, Kanyama C, Rezk NL, Mkupani P, Sichali D, Tien H, Kashuba AD, Mwansambo C, Weigel R, Kazembe P.
    Antivir Ther; 2010 Sep 10; 15(1):83-90. PubMed ID: 20167994
    [Abstract] [Full Text] [Related]

  • 5. A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T, Rao Thudi N, Koundinya Tippabhotla S, Khuroo A, Marwah A, Kumar Shrivastav V, Tandon M, Raghuvanshi R, Biswal S.
    Clin Ther; 2007 Dec 10; 29(12):2677-84. PubMed ID: 18201583
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of nevirapine, stavudine and lamivudine in Indian HIV-infected children receiving generic fixed dose combinations.
    Mukherjee A, Singla M, Velpandian T, Sirohiwal A, Vajpayee M, Singh R, Kabra SK, Lodha R.
    Indian Pediatr; 2014 Mar 10; 51(3):191-7. PubMed ID: 24736906
    [Abstract] [Full Text] [Related]

  • 7. Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
    L'homme RF, Kabamba D, Ewings FM, Mulenga V, Kankasa C, Thomason MJ, Walker AS, Chintu C, Burger DM, Gibb DM.
    AIDS; 2008 Mar 12; 22(5):557-65. PubMed ID: 18316996
    [Abstract] [Full Text] [Related]

  • 8. Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults.
    Byakika-Tusiime J, Chinn LW, Oyugi JH, Obua C, Bangsberg DR, Kroetz DL.
    PLoS One; 2008 Mar 12; 3(12):e3981. PubMed ID: 19096711
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.
    Hosseinipour MC, Corbett AH, Kanyama C, Mshali I, Phakati S, Rezk NL, van der Horst C, Kashuba AD.
    AIDS; 2007 Jan 02; 21(1):59-64. PubMed ID: 17148968
    [Abstract] [Full Text] [Related]

  • 10. Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.
    Ellis JC, L'homme RF, Ewings FM, Mulenga V, Bell F, Chileshe R, Molyneux E, Abernethy J, van Oosterhout JJ, Chintu C, Walker AS, Gibb DM, Burger DM.
    Antivir Ther; 2007 Jan 02; 12(2):253-60. PubMed ID: 17503667
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine.
    Chokephaibulkit K, Plipat N, Cressey TR, Frederix K, Phongsamart W, Capparelli E, Kolladarungkri T, Vanprapar N.
    AIDS; 2005 Sep 23; 19(14):1495-9. PubMed ID: 16135903
    [Abstract] [Full Text] [Related]

  • 12. Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults.
    Byakika-Kibwika P, Lamorde M, Kalemeera F, D'Avolio A, Mauro S, Di Perri G, Ryan M, Mayanja-Kizza H, Khoo S, Back D, Boffito M, Merry C.
    J Antimicrob Chemother; 2008 Nov 23; 62(5):1113-7. PubMed ID: 18641036
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of nevirapine in HIV-infected children with and without malnutrition receiving divided adult fixed-dose combination tablets.
    Pollock L, Else L, Poerksen G, Molyneux E, Moons P, Walker S, Fraser W, Back D, Khoo S.
    J Antimicrob Chemother; 2009 Dec 23; 64(6):1251-9. PubMed ID: 19812065
    [Abstract] [Full Text] [Related]

  • 14. Nevirapine/lamivudine/stavudine as a combined-formulation tablet: bioequivalence study compared with each component administered concurrently under fasting condition.
    Monif T, Tippabhotla SK, Garg M, Singla AK, Vijan T.
    Int J Clin Pharmacol Ther; 2006 Jun 23; 44(6):276-83. PubMed ID: 16800100
    [Abstract] [Full Text] [Related]

  • 15. A combined-formulation tablet of lamivudine/nevirapine/stavudine: bioequivalence compared with concurrent administration of lamivudine, nevirapine, and stavudine in healthy Indian subjects.
    Narang VS, Lulla A, Malhotra G, Purandare S.
    J Clin Pharmacol; 2005 Mar 23; 45(3):265-74. PubMed ID: 15703362
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
    Chokephaibulkit K, Cressey TR, Capparelli E, Sirisanthana V, Muresan P, Hongsiriwon S, Ngampiyaskul C, Limwongse C, Wittawatmongkol O, Aurpibul L, Kabat B, Toye M, Smith ME, Eksaengsri A, McIntosh K, Yogev R, IMPAACT P1069 Team.
    Antivir Ther; 2011 Mar 23; 16(8):1287-95. PubMed ID: 22155910
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of two generic fixed-dose combinations for HIV-infected children (Pedimune Baby & Pedimune Junior) are similar to the branded products in healthy adults.
    L'homme RF, Dijkema T, Warris A, van der Ven AJ, Gibb DM, Burger DM.
    J Antimicrob Chemother; 2007 Jan 23; 59(1):92-6. PubMed ID: 17071953
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous And Extended Delivery Of Stavudine, Lamivudine And Nevirapine In Fixed Dose Combination Using Sandwiched Osmotic Tablets For Hiv Therapy.
    Priya MR, Rajendran NN.
    Curr Drug Deliv; 2015 Jan 23; 12(5):600-12. PubMed ID: 25943763
    [Abstract] [Full Text] [Related]

  • 19. Steady-state nevirapine, lamivudine and stavudine levels in Malawian HIV-infected children on antiretroviral therapy using split Triomune 30 tablets.
    Poerksen G, Pollock L, Moons P, Chesshyre E, Burger D, Khoo S, Molyneux E.
    Antivir Ther; 2010 Jan 23; 15(3):343-50. PubMed ID: 20516554
    [Abstract] [Full Text] [Related]

  • 20. A single-dose, randomized, open-label, two-period crossover bioequivalence study comparing a fixed-dose pediatric combination of lamivudine and stavudine tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
    Monif T, Reyar S, Tiwari HK, Tippabhotla SK, Khuroo A, Thudi NR, Ahmed S, Raghuvanshi R.
    Arzneimittelforschung; 2009 Jan 23; 59(2):104-8. PubMed ID: 19338141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.